Consensus Estimate

Consensus Estimate

Vifor Pharma is covered by a number of Swiss and international financial analysts. The presentation below provides an overview of the consensus estimates drawn from their findings.

Any opinions, forecasts, estimates, projections or predictions that analysts make regarding the performance and business development of the Vifor Pharma Group are theirs alone and might differ from the opinions, forecasts, estimates, projections or predictions of Vifor Pharma or its management. Such analysts’ estimates and forecasts cannot be independently verified by reason of the subjective character. Financial forecasts are, by definition, forward looking and are therefore subject to various risks and uncertainties which are subject to change at any time. Vifor Pharma will not make any comment on the figures presented here and how they relate to its internal forecasts, estimates and projections, and by providing the names of the analysts, Vifor Pharma does not imply its endorsement of, or agreement with their reports, conclusions or recommendations.  

The presentation below is provided for your information only. Vifor Pharma assumes no liability for the accuracy of such information and undertakes no obligation to update or revise this presentation.